319 related articles for article (PubMed ID: 19516906)
1. Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis.
Xing Z; McFarland CT; Sallenave JM; Izzo A; Wang J; McMurray DN
PLoS One; 2009 Jun; 4(6):e5856. PubMed ID: 19516906
[TBL] [Abstract][Full Text] [Related]
2. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
Santosuosso M; McCormick S; Zhang X; Zganiacz A; Xing Z
Infect Immun; 2006 Aug; 74(8):4634-43. PubMed ID: 16861651
[TBL] [Abstract][Full Text] [Related]
3.
Jia Q; Masleša-Galić S; Nava S; Horwitz MA
mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
[TBL] [Abstract][Full Text] [Related]
4. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
[TBL] [Abstract][Full Text] [Related]
5. Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis.
Mu J; Jeyanathan M; Small CL; Zhang X; Roediger E; Feng X; Chong D; Gauldie J; Xing Z
Mol Ther; 2009 Jun; 17(6):1093-100. PubMed ID: 19319120
[TBL] [Abstract][Full Text] [Related]
6. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
[TBL] [Abstract][Full Text] [Related]
7. Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization.
Xing Z; Lichty BD
Tuberculosis (Edinb); 2006; 86(3-4):211-7. PubMed ID: 16504584
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
[TBL] [Abstract][Full Text] [Related]
9. Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs.
Nangpal P; Bahal RK; Tyagi AK
Sci Rep; 2017 Dec; 7(1):17286. PubMed ID: 29230061
[TBL] [Abstract][Full Text] [Related]
10. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
11. Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis.
Pérez de Val B; Villarreal-Ramos B; Nofrarías M; López-Soria S; Romera N; Singh M; Abad FX; Xing Z; Vordermeier HM; Domingo M
Clin Vaccine Immunol; 2012 Sep; 19(9):1339-47. PubMed ID: 22761299
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
Williams A; Hatch GJ; Clark SO; Gooch KE; Hatch KA; Hall GA; Huygen K; Ottenhoff TH; Franken KL; Andersen P; Doherty TM; Kaufmann SH; Grode L; Seiler P; Martin C; Gicquel B; Cole ST; Brodin P; Pym AS; Dalemans W; Cohen J; Lobet Y; Goonetilleke N; McShane H; Hill A; Parish T; Smith D; Stoker NG; Lowrie DB; Källenius G; Svenson S; Pawlowski A; Blake K; Marsh PD
Tuberculosis (Edinb); 2005; 85(1-2):29-38. PubMed ID: 15687025
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.
Gupta T; LaGatta M; Helms S; Pavlicek RL; Owino SO; Sakamoto K; Nagy T; Harvey SB; Papania M; Ledden S; Schultz KT; McCombs C; Quinn FD; Karls RK
Tuberculosis (Edinb); 2018 Dec; 113():179-188. PubMed ID: 30514501
[TBL] [Abstract][Full Text] [Related]
14. Heterologous Boosting With
Liu SJ; Tian SC; Zhang YW; Tang T; Zeng JM; Fan XY; Wang C
Front Immunol; 2020; 11():2036. PubMed ID: 32983151
[TBL] [Abstract][Full Text] [Related]
15. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
16. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
[TBL] [Abstract][Full Text] [Related]
17. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
[TBL] [Abstract][Full Text] [Related]
18. Parenteral adenoviral boost enhances BCG induced protection, but not long term survival in a murine model of bovine TB.
Kaveh DA; Garcia-Pelayo MC; Webb PR; Wooff EE; Bachy VS; Hogarth PJ
Vaccine; 2016 Jul; 34(34):4003-11. PubMed ID: 27317453
[TBL] [Abstract][Full Text] [Related]
19. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
Clark S; Lanni F; Marinova D; Rayner E; Martin C; Williams A
J Infect Dis; 2017 Sep; 216(5):525-533. PubMed ID: 28329234
[TBL] [Abstract][Full Text] [Related]
20. Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model.
Damjanovic D; Khera A; Afkhami S; Lai R; Zganiacz A; Jeyanathan M; Xing Z
PLoS One; 2015; 10(6):e0131175. PubMed ID: 26098423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
